Greater rates of patients with PsO achieved concurrent complete skin and nail clearance with bimekizumab vs adalimumab, ustekinumab, and secukinumab.

Repeated trauma may also produce ingrown hairs and chronic follicular inflammation, which further increases infection risk.

Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more ...